Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/109754
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.contributorDepartment of Applied Mathematicsen_US
dc.creatorYang, Yen_US
dc.creatorTse, YSen_US
dc.creatorZhang, Qen_US
dc.creatorWong, KYen_US
dc.creatorYang, Cen_US
dc.creatorYang, Yen_US
dc.creatorLi, Sen_US
dc.creatorLau, KWen_US
dc.creatorCharles, TCen_US
dc.creatorLam, TCen_US
dc.creatorZhao, Qen_US
dc.date.accessioned2024-11-14T06:42:40Z-
dc.date.available2024-11-14T06:42:40Z-
dc.identifier.issn0022-2623en_US
dc.identifier.urihttp://hdl.handle.net/10397/109754-
dc.language.isoenen_US
dc.publisherAmerican Chemical Societyen_US
dc.titleMultiplexed target profiling with integrated chemical genomics and chemical proteomicsen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage17542en_US
dc.identifier.epage17550en_US
dc.identifier.volume67en_US
dc.identifier.issue19en_US
dc.identifier.doi10.1021/acs.jmedchem.4c01463en_US
dcterms.abstractTarget identification is crucial for elucidating the mechanisms of bioactive molecules in drug discovery. However, traditional methods assess compounds individually, making it challenging to efficiently examine multiple compounds in parallel, especially for structurally diverse compounds. This study reports a novel strategy called chemical genomics-facilitated chemical proteomics (CGCP) for multiplexing the target identification of bioactive small molecules. CGCP correlates compounds’ perturbation of global transcription, or chemical genomic profiles, with their reactivity toward target proteins, enabling simultaneous identification of targets. We demonstrated the utility of CGCP by studying the targets of celastrol (Cel) and four other electrophilic compounds with varying levels of similarity to Cel based on their chemical genomic profiles. We identified multiple novel targets and binding sites shared by the compounds in a single experiment. CGCP enabled multiplexity and improved the efficiency of target identification for structurally distinct compounds, indicating its potential to accelerate drug discovery.en_US
dcterms.accessRightsembargoed accessen_US
dcterms.bibliographicCitationJournal of medicinal chemistry, 10 Oct. 2024, v. 67, no. 19, p. 17542-17550en_US
dcterms.isPartOfJournal of medicinal chemistryen_US
dcterms.issued2024-10-10-
dc.identifier.eissn1520-4804en_US
dc.description.validate202411 bcchen_US
dc.description.oaNot applicableen_US
dc.identifier.FolderNumbera3281-
dc.identifier.SubFormID49875-
dc.description.fundingSourceOthersen_US
dc.description.fundingTextNSFC 21705136en_US
dc.description.pubStatusPublisheden_US
dc.date.embargo2025-09-28en_US
dc.description.oaCategoryGreen (AAM)en_US
Appears in Collections:Journal/Magazine Article
Open Access Information
Status embargoed access
Embargo End Date 2025-09-28
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

9
Citations as of Nov 17, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.